Compare IDXX & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | GFS |
|---|---|---|
| Founded | 1983 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4B | 37.8B |
| IPO Year | 1996 | 2017 |
| Metric | IDXX | GFS |
|---|---|---|
| Price | $555.34 | $47.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $721.67 | $45.08 |
| AVG Volume (30 Days) | 612.4K | ★ 4.3M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.59 | N/A |
| EPS | ★ 7.74 | N/A |
| Revenue | ★ $4,303,702,000.00 | N/A |
| Revenue This Year | $10.88 | $7.64 |
| Revenue Next Year | $8.59 | $9.90 |
| P/E Ratio | $71.95 | ★ $29.28 |
| Revenue Growth | ★ 10.42 | N/A |
| 52 Week Low | $518.55 | $31.61 |
| 52 Week High | $769.98 | $92.55 |
| Indicator | IDXX | GFS |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 36.95 |
| Support Level | $536.07 | $46.38 |
| Resistance Level | $583.93 | $49.36 |
| Average True Range (ATR) | 19.39 | 2.62 |
| MACD | -3.47 | 0.40 |
| Stochastic Oscillator | 17.37 | 9.45 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and has about 13,000 staff.